Selective estrogen targeting to protect the heart and blood vessels

Diseases of the blood vessels and heart, which are known as cardiovascular diseases, are the most common causes of death in the US. They include heart failure and atherosclerosis (also known as hardening of the arteries), which is a common cause of heart attack and stroke.

The is thought to have cardiovascular protective effects.

However, hormone therapy with estrogen alone increases the risk of uterine cancer in women.

By dissecting the different pathways by which estrogen signals to cells in mice, a team of researchers, led by Philip Shaul, at the University of Texas Southwestern Medical Center, Dallas, has now determined that it might be possible to selectively harness the cardiovascular benefits of estrogen.

Specifically, the team found that an estrogen-dendrimer conjugate that activated only the subset of estrogen receptors (the proteins to which estrogen binds to mediate its effects) that reside at the cell membrane, and not those in the nucleus, promoted cardiovascular protection in mice and did not stimulate either uterine enlargement or xenograft growth.

In an accompanying commentary, Michael Mendelsohn and Richard Karas, at Tufts Medical Center, Boston, suggest that, "translation of these findings into clinically relevant therapeutic interventions is a logical next goal." However, they caution that there is a long road ahead to realizing this goal.

Explore further

Cholesterol byproduct blocks heart health benefits of estrogen

More information:
-- Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. View this article at: … c015821411b383d31bcb
-- Rapid progress for non-nuclear estrogen receptor signaling. View this article at: … 7a8813a647a56ec32c16
Provided by Journal of Clinical Investigation
Citation: Selective estrogen targeting to protect the heart and blood vessels (2010, June 23) retrieved 13 December 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments